Search clinical trials for: follitropin beta

Total 6134 results

Asan Medical Center

Unknown

Effect of Preoperative Beta Blocker Use Postoperative Renal Function in the Patients Undergoing Liver Transplantation

End Stage Liver Disease | Acute Kidney Injury

Korea, Republic of
Merck KGaA, Darmstadt, Germany

Completed

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®) (TOURIMS)

Relapsing-Remitting Multiple Sclerosis
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects

Bacterial Infections | Healthy Volunteers

Australia
National Eye Institute (NEI)

Unknown

Collaborative Initial Glaucoma Treatment Study (CIGTS)

Open-Angle Glaucoma
Samuel Brown
Beth Israel Deaconess Medical Center

Unknown

Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2 (ECASSS-R2)

Septic Shock

United States
Yungjin Pharm. Co., Ltd.
KT&G Corporation

Completed

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Obesity | Metabolic Syndrome
Azidus Brasil

Completed

Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects

Healthy

Brazil
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

Recurrent Merkel Cell Carcinoma | Stage IV Merkel Cell Carcinoma

United States
Novo Nordisk A/S

Completed

Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

Healthy | Menopause

Germany
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts | High Risk Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Acute Myeloid... and other conditions

United States
East Coast Institute for Research

Completed

Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function

Hypertension | Female Sexual Dysfunction

United States
Diskapi Teaching and Research Hospital

Completed

A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol in Intracranial Surgery

Myocardial Ischemia | Hypertension | Tachycardia

Turkey
Fred Lublin
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx

Relapsing Remitting Multiple Sclerosis

United States, Canada
Sara Thønnings

Withdrawn

Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia

Bacteremia
Trinity Hypertension & Metabolic Research Institute

Completed

Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine

JNC 7 Stage 1 or 2 Hypertension

United States
Tartu University Hospital

Completed

The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker

Aortic Blood Pressure
USANA Health Sciences
Elegant And Olive Health Clinic, Canada

Completed

A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM Condition

Protective Qi Insufficiency (a Condition Term From TCM)

Canada
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Lung Cancer

United States
Ultragenyx Pharmaceutical Inc

Completed

A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)

Mucopolysaccharidosis | Sly Syndrome | MPS VII | MPS 7

United States
Nottingham Trent University

Suspended

The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60s

Muscle Function
Groupe Francophone des Myelodysplasies

Completed

Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS) (EPO-QoL)

Myelodysplastic Syndromes

France
National Taiwan University Hospital

Completed

To Study the Effect of β-glucans on Wound Healing

Burns

Taiwan
Hoffmann-La Roche

Completed

An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia

Anemia

Morocco
Biotec Pharmacon ASA

Completed

Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Norway
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

Acute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | Myeloproliferative Neoplasm | Myeloid Sarcoma | Blasts 10 Percent or More of Bone Marrow Nucleated Cells

United States
University of Nebraska
National Cancer Institute (NCI)

Active, not recruiting

Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia

United States
University of Washington
National Cancer Institute (NCI); Bayer

Completed

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | de Novo Myelodysplastic Syndrome | Acute Biphenotypic Leukemia

United States
University of Washington
National Cancer Institute (NCI)

Completed

Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm

Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Myeloid Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia

United States
University of Florida
Danstar Ferment AG

Active, not recruiting

Beta-glucan and Immune Response to Influenza Vaccine (M-Unity)

Healthy Aging

United States
Nottingham Trent University

Completed

β-alanine Supplementation on Knee Extensor Contractile and Force Properties

Muscle Function
Radboud University Medical Center

Completed

Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans (BG)

Immunologic Deficiency Syndromes

Netherlands
University Hospital, Grenoble
Roche Pharma AG

Completed

Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB (EPOetCEC)

Myocardial Ischemia

France
University of Cambridge
Hoffmann-La Roche; Roche Foundation of Anemia Research (RoFAR, Switzerland)

Completed

Erythropoietin Therapy for Subarachnoid Hemorrhage

Aneurysmal Subarachnoid Hemorrhage

United Kingdom
Claudio Gobbi
Bayer

Terminated

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis

Switzerland
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients (SEPTIME)

Multiple Sclerosis, Relapsing, Remitting
National Cancer Institute (NCI)

Not yet recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia
National Cancer Institute (NCI)

Active, not recruiting

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome/Acute Myeloid Leukemia

United States
Fundación para la Investigación del Hospital Clínico...

Completed

β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR) (Preserve-HR)

Heart Failure With Normal Ejection Fraction | Chronotropic Incompetence

Spain
Intermountain Health Care, Inc.
Beth Israel Deaconess Medical Center

Completed

Esmolol Infusion for Patients With Septic Shock and Persistent Tachycardia (ECASSS-R)

Septic Shock

United States
Yungjin Pharm. Co., Ltd.
KT&G Corporation

Completed

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Obesity | Metabolic Syndrome

Korea, Republic of
Biogen

Completed

Immunogenicity and Safety Study of Serum-Free Avonex

Multiple Sclerosis
Bnai Zion Medical Center

Unknown

Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease

Crohn's Disease

Israel
Women and Infants Hospital of Rhode Island
Patient-Centered Outcomes Research Institute; University of California, San... and other collaborators

Recruiting

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence (BEST)

Urgency Urinary Incontinence

United States
University of Chicago
Washington University School of Medicine; National Heart, Lung, and Blood Institute...

Completed

Metoprolol to Reduce Perioperative Myocardial Injury (ORION)

Heart Diseases

United States
Hospital Kemaman

Completed

Acute Tocolysis With Terbutaline for Suspected Fetal Distress

Nonreassuring Fetal Status

Malaysia
Biogen

Completed

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Multiple Sclerosis

United States
Institute of Liver and Biliary Sciences, India

Withdrawn

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Advanced Cirrhosis

India
National Institute of Neurological Disorders and...

Completed

Safety Study of Interferon Beta 1a to for Acute Stroke

Cerebrovascular Accident

United States
Kaiser Permanente
Agency for Healthcare Research and Quality (AHRQ)

Completed

HMO Research Network CERT: Acute Myocardial Infarction

Acute Myocardial Infarction (AMI)

United States

Search clinical trials for: follitropin beta

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations